⌘K

Login Start Free

Home/Filings/4/0001140361-16-049538

4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0001140361-16-049538

$IRDCIK 0001228627operating

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:32 PM ET

Size

7.6 KB

Accession

0001140361-16-049538

Insider Transaction Report

Form 4

Period: 2016-01-28

REXAHN PHARMACEUTICALS, INC.RNN

DirectorChairman & CEO

Transactions

Award
Stock Option (right to buy)
2016-01-28+200,000→ 200,000 total
Exercise: $0.35Exp: 2026-01-28→ Common Stock (200,000 underlying)
Award
Stock Option (right to buy)
2016-01-28+214,461→ 214,461 total
Exercise: $0.35From: 2017-01-28Exp: 2026-01-28→ Common Stock (214,461 underlying)

Footnotes (1)

[F1]One quarter of the option vests and becomes exercisable on January 28, 2017, and thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month following such date until fully vested.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001228627

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 4:32 PM ET
Size: 7.6 KB

View on SEC.gov